Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations
Markku Lähteenvuo(University of Eastern Finland), Jari Tiihonen(University of Eastern Finland)
Cited by 147
Related Papers
Mortality in people with schizophrenia: a systematic review and meta‐analysis of relative risk and aggravating or attenuating factors
|World Psychiatry|2022|624
Growth Factor Therapy and Autologous Lymph Node Transfer in Lymphedema
|Circulation|2011|181
Real-world Effectiveness of Pharmacologic Treatments for the Prevention of Rehospitalization in a Finnish Nationwide Cohort of Patients With Bipolar Disorder
|JAMA Psychiatry|2018|147
Antipsychotic use and risk of breast cancer in women with schizophrenia: a nationwide nested case-control study in Finland
|The Lancet Psychiatry|2021|137